Literature DB >> 13816523

Transplacental transmission of busulfan (myleran) in a mother with leukemia. Production of fetal malformation and cytomegaly.

I DIAMOND, M M ANDERSON, S R McCREADIE.   

Abstract

Entities:  

Keywords:  ABNORMALITIES/etiology; BUSULFAN/toxicology; LEUKEMIA/in pregnancy; PREGNANCY/complications

Mesh：

Substances：

Year:  1960        PMID： 13816523

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


× No keyword cloud information.
  9 in total

Review 1.  Antineoplastic and immunosuppressive drugs. 3. Adverse effects and therapeutic problems.

Authors:  M D Cridland
Journal:  Drugs       Date:  1972       Impact factor: 9.546

2.  Proceedings: The effect of immunosuppression on cancer.

Authors:  I Penn; T E Starzl
Journal:  Proc Natl Cancer Conf       Date:  1972

3.  Adrenal cytomegaly.

Authors:  K Aterman; N Kerenyi; M Lee
Journal:  Virchows Arch A Pathol Pathol Anat       Date:  1972

4.  On the effects of blastomogenic substances on the organism during embryogenesis.

Authors:  N P Napalkov; V A Alexandrov
Journal:  Z Krebsforsch       Date:  1968

5.  Developmental pharmacology.

Authors:  A S Sethi; S Sinclair
Journal:  Indian J Pediatr       Date:  1968-08       Impact factor: 1.967

6.  Busulphan lung.

Authors:  B E Heard; R A Cooke
Journal:  Thorax       Date:  1968-03       Impact factor: 9.139

7.  Occupational chemicals tested for teratogenicity.

Authors:  K Hemminki
Journal:  Int Arch Occup Environ Health       Date:  1980       Impact factor: 3.015

Review 8.  Transplacental Passage and Fetal Effects of Antineoplastic Treatment during Pregnancy.

Authors:  Silvia Triarico; Serena Rivetti; Michele Antonio Capozza; Alberto Romano; Palma Maurizi; Stefano Mastrangelo; Giorgio Attinà; Antonio Ruggiero
Journal:  Cancers (Basel)       Date:  2022-06-24       Impact factor: 6.575

Review 9.  Species sensitivities and prediction of teratogenic potential.

Authors:  J L Schardein; B A Schwetz; M F Kenel
Journal:  Environ Health Perspect       Date:  1985-09       Impact factor: 9.031
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.